Related Experiment Video

Updated: Oct 3, 2025

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

2.3K

P53: Stability from the Ubiquitin-Proteasome System and Specific 26S Proteasome Inhibitors

Andressa Barban do Patrocinio1, Vanderlei Rodrigues2, Lizandra Guidi Magalhães1

  • 1Research Group on Natural Products (Center for Research in Sciences and Technology), Universidade de Franca, Av. Dr. Armando de Sales Oliveira, 201 - Parque Universitário, Franca, São Paulo 14404-600, Brazil.

ACS Omega
|February 14, 2022
PubMed

Insights

The ubiquitin-proteasome system degrades protein p53. Inhibitors of this system stabilize p53, offering potential cancer treatments by preserving tumor suppressor functions.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cellular Biology

Background:

  • The 26S proteasome is a crucial cellular complex responsible for protein degradation.
  • Protein p53, a key tumor suppressor, is regulated by the ubiquitin-proteasome system.
  • Ubiquitination, involving E1, E2, and E3 enzymes, targets proteins like p53 for proteasomal degradation.

Purpose of the Study:

  • To review the intricate relationship between the ubiquitin-proteasome system, protein p53, and therapeutic compounds.
  • To elucidate the mechanisms by which proteasome inhibitors impact p53 stability and function.
  • To highlight the therapeutic potential of targeting the ubiquitin-proteasome pathway in diseases like cancer.

Main Methods:

  • Literature review of studies on the ubiquitin-proteasome system and p53.
  • Analysis of the role of E3 ubiquitin ligases in p53 degradation.
  • Examination of the mechanisms of action for 26S proteasome inhibitors.

Main Results:

  • The ubiquitin-proteasome system critically controls p53 stability through ubiquitination.
  • E3 ubiquitin ligases are key regulators of p53 degradation.
  • Proteasome inhibitors can stabilize p53, impacting cellular pathways relevant to cancer therapy.

Conclusions:

  • The ubiquitin-proteasome system and p53 are tightly linked, with implications for cellular regulation.
  • Targeting the 26S proteasome with specific inhibitors offers a therapeutic strategy for diseases involving p53 dysregulation.
  • Understanding these interactions is vital for developing novel cancer treatments.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

9.7K
Assays for the Degradation of Misfolded Proteins in Cells10:56

Assays for the Degradation of Misfolded Proteins in Cells

Published on: August 28, 2016

12.2K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
7.7K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.4K
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.8K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.4K
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.2K